![](https://www.molecular-medicine-israel.co.il/wp-content/uploads/2018/01/heterogenous-tumor-300x300.jpg)
Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy
Highlights •Anti-cancer drugs have variable efficacy within patient populations •Drug combinations give each patient more chances that one drug could be effective •Clinical efficacy of